Literature DB >> 12502384

Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.

Thomas Kislinger1, Andreas Humeny, Carlo C Peich, Xiaohong Zhang, Toshimitsu Niwa, Monika Pischetsrieder, Cord-Michael Becker.   

Abstract

The nonenzymatic glycation of proteins by reducing sugars, also known as the Maillard reaction, has received increasing recognition from nutritional science and medical research. In this study, we applied matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) to perform relative and simultaneous quantification of the Amadori product, which is an early glycation product, and of N(epsilon)-(carboxymethyl)lysine and imidazolone A, two important advanced glycation end products. Therefore, native lysozyme was incubated with d-glucose for increasing periods of time (1, 4, 8, and 16 weeks) in phosphate-buffered saline pH 7.8 at 50 degrees C. After enzymatic digestion with endoproteinase Glu-C, the N-terminal peptide fragment (m/z 838; amino acid sequence KVFGRCE) and the C-terminal peptide fragment (m/z 1202; amino acid sequence VQAWIRGCRL) were used for relative quantification of the three Maillard products. Amadori product, N(epsilon)-(carboxymethyl)lysine, and imidazolone A were the main glycation products formed under these conditions. Their formation was dependent on glucose concentration and reaction time. The kinetics were similar to those obtained by competitive ELISA, an established method for quantification of N(epsilon)-(carboxymethyl)lysine and imidazolone A. Inhibition experiments showed that coincubation with N(alpha)-acetylargine suppressed formation of imidazolone A but not of the Amadori product or N(epsilon)-(carboxymethyl)lysine. The presence of N(alpha)-acetyllysine resulted in the inhibition of lysine modifications but in higher concentrations of imidazolone A. o-Phenylenediamine decreased the yield of the Amadori product and completely inhibited the formation of N(epsilon)-(carboxymethyl)lysine and imidazolone A. MALDI-TOF-MS proved to be a new analytical tool for the simultaneous, relative quantification of specific products of the Maillard reaction. For the first time, kinetic data of defined products on specific sites of glycated protein could be measured. This characterizes MALDI-TOF-MS as a valuable method for monitoring the Maillard reaction in the course of food processing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502384     DOI: 10.1021/jf020768y

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  5 in total

1.  Effect of chemical chaperones on glucose-induced lysozyme modifications.

Authors:  S Zahra Bathaie; B B Fateme Nobakht; Hossein Mirmiranpour; Akbar Jafarnejad; S Zahra Moosavi-Nejad
Journal:  Protein J       Date:  2011-10       Impact factor: 2.371

2.  Determination of dideoxyosone precursors of AGEs in human lens proteins.

Authors:  Mikhail Linetsky; S R Kaid Johar; Jasmin Meltretter; Smitha Padmanabha; Trilok Parmar; Abhay R Vasavada; Monika Pischetsrieder; Ram H Nagaraj
Journal:  Arch Biochem Biophys       Date:  2011-07-28       Impact factor: 4.013

3.  Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Omar S Barnaby; Chunling Wa; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-04-13       Impact factor: 3.786

Review 4.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

5.  Investigating the Glycating Effects of Glucose, Glyoxal and Methylglyoxal on Human Sperm.

Authors:  Clare Nevin; Lauren McNeil; Nessar Ahmed; Chris Murgatroyd; Daniel Brison; Michael Carroll
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.